Indaptus Therapeutics Inc. - Common Stock, $0.01 par value (INDP)

CUSIP: 45339J105

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
113,265,306
Total 13F shares
541,295
Share change
+541,295
Total reported value
$4,239,000
Price per share
$7.83
Number of holders
9
Value change
+$4,239,000
Number of buys
9

Quarterly Holders Quick Answers

What is CUSIP 45339J105?
CUSIP 45339J105 identifies INDP - Indaptus Therapeutics Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Indaptus Therapeutics Inc. - Common Stock, $0.01 par value (INDP) as of Q3 2021

As of 30 Sep 2021, Indaptus Therapeutics Inc. - Common Stock, $0.01 par value (INDP) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 541,295 shares. The largest 9 holders included ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, INVESTMENT HOUSE LLC, CITADEL ADVISORS LLC, MARSHALL WACE, LLP, Harel Insurance Investments & Financial Services Ltd., MORGAN STANLEY, and UBS Group AG. This page lists 9 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.